Pittsburgh Start-Up Behaivior To Predict Relapse Through Artificial Intelligence & Wearable

The new Behaivior start-up wants to merge artificial intelligence with wearable devices to predict relapse danger for recovering opioid users. IBM Watson AI XPRIZE participants Ryan O’Shea, Jeremy Guttman, Ellie Gordon, and James Tiu have a goal to combine treatment for opioid use with machine learning to predict behavior to create this innovative ability.

If successfully implemented, the device would gather data, such as elevated body responses or notifications of missed counseling appointments, to determine when a candidate might be in danger of a relapse. The determination would happen through a predictive model, and a message or alert . . .